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Abstract
Background: Phospho-tau deposition has been described in a rare genetic human prion disease, Gerstmann-
Sträussler-Scheinker syndrome, but is not common neuropathological picture for other human and animal 
transmissible spongiform encephalopathies (TSEs). This study investigated the possible changes of tau and 
phosphorylated tau (p-tau, at Ser396, Ser404, and Ser202/Thr205) in scrapie experimental animals.
Methods: The profiles of tau and p-tau (p-tau, at Ser396, Ser404, and Ser202/Thr205) in the brain tissues of agents 
263K- or 139A-infected hamsters were evaluated by Western blots and real-time PCR. Meanwhile, the transcriptional 
and expressive levels of GSK3β and CDK5 in the brains were tested.
Results: The contents of total tau and p-tau at Ser202/Thr205 increased, but p-tau at Ser396 and Ser404 decreased at 
the terminal stages, regardless of scrapie strains. Transcriptional levels of two tau isoforms were also increased. 
Additionally, it showed higher CDK5, but lower GSK3β transcriptional and expressive levels in the brains of scrapie-
infected animals. Analysis of brain samples collected from different times after inoculated with agent 263 K revealed 
that the changes of tau profiles and phosphate kinases were time-relative events.
Conclusion: These data suggest that changes of profiles of p-tau at Ser396, Ser404 and Ser202/Thr205 are illness-
correlative phenomena in TSEs, which may arise of the alteration of phosphate kinases. Alteration of tau, p-tau (Ser396, 
Ser404, and Ser202/Thr205), GSK3β and CDK5 were either intermediate or consequent events in TSE pathogenesis and 
proposed the potential linkage of these bioactive proteins with the pathogenesis of prion diseases.
Background
Prion diseases, also known as transmissible spongiform
encephalopathies (TSEs) are a group of fatal neurodegen-
erative diseases of animals and humans causing severe
s p o n g i f o r m  d e g e n e r a t i o n  a n d  n e u r o n a l  l o s s  i n  c e n t r a l
nervous system (CNS). This relatively diverse group
includes bovine spongiform encephalopathy in cattle
(BSE), scrapie in sheep and goat, chronic wasting disease
(CWD) in deer and elk, and kuru, Creutzfeldt-Jakob dis-
ease (CJD), fatal familial insomnia (FFI) and Gerstmann-
Sträussler-Scheinker (GSS) disease in humans [1,2]. Clin-
ically, prion diseases can exhibit sporadic, inherited, or
infectious presentations. Regardless of the primary etiol-
ogy, the central event in the pathogenesis is the confor-
mational conversion from the cellular prion protein
(PrPC) into its insoluble and protease-resistant forms
(termed PrPSc) that accumulate in CNS [1].
The microtubule-associated protein tau, is a group of
molecular mass of 45-66 kDa proteins encoded by alter-
native splicing of a single gene [3]. There are six predomi-
nant tau isoforms in human brain containing 352-441
amino acids [4]. Hyperphosphorylated tau aggregated
into paired helical filaments, which is the main compo-
nent of neurofibrillary tangles found in the brains of
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Alzheimer's disease (AD) patients [5]. The main aber-
rantly hyperphosphorylated sites on tau include the
phospho-sites Ser-202/Thr-205 (AT8 site), Ser-214 and/
or Ser-212 (AT100 site), Thr-231 and/or Ser-235 (TG3
site), and Ser-396/Ser-404 (PHF-1 site) [6]. Precise regu-
lation of phosphorylation of tau is probably important for
its normal cellular functions and aberrant tau phosphory-
lation is believed to disrupt cellular processes such as
axonal transport [7].
The normal phosphorylation state of tau is balanced by
antagonistic kinase and phosphatase activity. Some
kinases and phosphatases have been implicated in the
abnormal hyperphosphorylation of tau [7]. The proline-
directed Serine/Threonine kinases, cyclin-dependent
kinase 5 (CDK5) and glycogen synthase kinase 3β
(GSK3β) have been identified as prime candidates medi-
ating aberrant tau phosphorylation at disease-associated
sites [8]. CDK5 co-localizes with filamentous tau deposits
and has increased activity in several tauopathies, such as
AD [9]. GSK3β generates disease associated phospho-
epitopes on tau [10] and co-localizes with aggregates of
hyperphosphorylated tau [11]. Obtained data show that
apoptotic neuronal death caused by PrP106-126 is in part
due to CDK5 deregulation, causing tau hyperhosphoryla-
tion at Ser202/Thr205 and apoptotic death. The inhibi-
tors of CDK5 and calpain reverted tau
hyperphosphorylation and prevented neuronal death
caused by PrP106-126 [12]. Over-activation of CDK5 in
young transgenic animals does not induce tau hyperphos-
phorylation at sites recognized by the antibodies AT8,
AT100, PHF-1 and TG3, while increased GSK3β activity
coincides with tau hyperphosphorylation at the AT8 and
PHF-1 sites, which reveales the role of GSK3β as a key
mediator of tau hyperphosphorylation, whereas CDK5
acts as a modulator of tau hyperphosphorylation via the
inhibitory regulation of GSK3β [7]. Both GSK3β and
CDK5 can phosphorylate tau at many positions, e.g.
Thr181, Ser199, Ser202, Thr205, Thr212, Thr217, Ser396,
and Ser404. However, GSK3β seems to prefer phosphory-
lating tau at its microtubule binding domains in the C-
terminus, while CDK5 tends to target the N-terminus
[13].
Human prion diseases share some clinical and neuro-
pathological features with AD. Both are dementia disor-
ders, whose pathogeneses are related to the deposition of
abnormal proteins in the extracellular space of the brain
and this change is considered to have a crucial role in
causing the degeneration and death of neuronal cells. On
the other hand, the two diseases have distinct natural
processes. CJD is a unique transmissible encephalopathy
and the clinical course is much shorter than AD. In spo-
radic CJD, PrPSc builds up in the gray matter mostly in
diffuse form and tau pathology is not considered part of
the neuropathological picture [14]. Although there are
some reports about Alzheimer-type changes in CJD
patients [15,16], these cases are elder patients, in which
neurofibrillary changes are associated with Aβ deposits,
likely representing the co-occurrence of CJD with AD or
age-related phenomena. In the brain tissues of GSS, a
familial prion disease caused by specific mutations of the
PrP gene (PRNP), abundant hyperphosphorylated tau (p-
tau) depositions have been documented [17]. To date,
phospho-tau-related changes have been rarely reported
in patients with vCJD [18,19], but one study describes
that phospho-tau often clusters around PrP amyloid
deposits in the brains of five vCJD patients and the mouse
models of vCJD [20]. Besides, hyperphosphorylation of
tau protein has been previously reported in bovine PrP
transgenic mice infected with BSE [21].
In the present study, the relative quantity of total tau
protein and its phosphorylated status at Ser396, Ser404,
and Ser202/Thr205 in the brain tissues of the hamsters
infected with scrapie agent 263 K or 139 A at their clinical
terminal stages were evaluated. Western blots revealed
that the amounts of total tau and p-tau at Ser202/Thr205
increased, but the levels of p-tau at Ser396 and Ser404
decreased. Transcription of two tau isoforms was also
increased. In parallel, the expression and transcription of
GSK3β were depressed, while those of CDK5 were
increased in the brains of scrapie-infected animals.
Methods
Animal brain samples infected with scrapie agents
Five Chinese golden hamsters inoculated intracerebrally
with hamster-adapted scrapie agent 263 K and five ham-
sters inoculated intracerebrally with mouse-adapted
scrapie agent 139 A were included in this study. Previ-
ously studies confirmed that the incubation time of 263K-
infected hamsters was 79.1 ± 8.6 days [22], while that of
139A-infected hamsters was 395 ± 8.5 days [23]. The
brains were removed surgically within 8 hrs after natural
death or at the moribund stage. The brains were immedi-
ately dissected, then frozen and stored at -80°C until use.
Besides, two brain samples of the agent 263K-infected
hamsters at the 20th, 40th, 50th, 60th and 70th days after
inoculation were collected. Besides, eight normal ham-
sters were enrolled as controls.
Preparation of brain tissue samples
Brain homogenates of the hamsters were prepared
described previously [24], with slight modification. Brain
samples from the scrapie-infected and healthy hamsters
were washed in TBS (10 mM Tris HCl, 133 mM NaCl, pH
7.4) for three times, and then 10% (W/V) brain homoge-
nates were prepared in lysis buffer (100 mM NaCl, 10
mM EDTA, 0.5% Nonidet P-40, 0.5% sodium deoxy-
cholate, 10 mM Tris, pH 7.5) containing a mixture of pro-Wang et al. BMC Infectious Diseases 2010, 10:86
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tease inhibitors. The tissue debris was removed by low-
speed centrifugation at 2,000 g for 10 min and the super-
natants were used for further experiments.
Protease Resistance Assay
For detection of PrPSc in brain tissues, all tested brain
homogenates were digested with a final concentration of
50 μg/ml proteinase K (PK) at 37°C for 60 min prior to
Western blot, digestion was terminated by addition of
PMSF to a final concentration of 5 mM and boiling in
SDS-PAGE sample buffer.
Antibodies
Anti-tau monoclonal antibody (mAb) tau13, and anti-β-
actin mAb were purchased from Santa Cruz Biotechnol-
ogy. Anti-PrP mAb 3F4 was purchased from Dako. Anti-
p-tau (Ser396) polyclonal antibody (pAb) TAU [pS396],
Anti-p-tau (Ser404) pAb TAU [pS404], Anti-GSK3β
mAb, and Anti-CDK5 mAb were purchased from Bio-
source. Anti-p-tau (Ser202/Thr205) mAb AT8 was pur-
chased from Pierce Endogen.
Western blot analysis
Samples were separated by 15% SDS-PAGE and electrob-
lotted onto a nitrocellulose membrane using a semi-dry
blotting system (Bio-rad). Membranes were blocked with
5% (w/v) non-fat milk powder (NFMP) in 1 × Tris-buff-
ered saline containing 0.1% Tween 20 (NFMP-TBST) at
room temperature for 1 h and probed with mAb 3F4
(1:5000), mAb tau13 (1:4000), pAb TAU [pS396] (1:1000),
pAb TAU [pS404] (1:1000), mAb AT8 (1:4000), anti-
GSK3β mAb (1:4000), Anti-CDK5 mAb (1:4000) and
anti-β-actin mAb (1:2000) at 4°C overnight, respectively.
After washing three times with TBST, blots were incu-
bated in HRP-conjugated secondary antibody solutions,
1:5,000-diluted HRP-conjugated goat anti-rabbit IgG or
goat anti-mouse IgG (Santa Cruz, CA, USA), at room
temperature for 2 h. Blots were developed using
Enhanced ChemoLuminescence system (ECL, Amer-
sham Life Sciences, Buckinghamshire, UK) and visualized
on autoradiography films.
Real Time Reverse Transcription PCR
Total RNA from the brain of normal and scrapie-infected
hamsters were extracted using the TRIzol (Invitrogen)
reagent according to the manufacturer's instructions.
Reverse transcription was performed using SuperScript™
III First-Strand Synthesis System (Invitrogen). Briefly, 2
μg of total RNA was mixed with 200 U of MMLV reverse
transcriptase and 50 pM oligo (dT20) in a volume of 20
μl. The mixtures were maintained at 50°C for 50 min and
inactivated by heating at 85°C for 5 min. To remove the
RNA from the cDNA, 1 μl E. coli RNase H was added to
the mixture and incubated at 37°C for 20 min. Aliquots (2
μl) of RT reaction products were amplified by PCR. The
primers used were designed and synthesized according to
the published literatures. Since no respective hamster's
data available in GenBank, the primers were based on the
individual sequences of mouse, including the primers for
tau, Tau2-sence 5'-TCG CCA GGA GTT TGA CAC AAT
GGA-3', Tau4-sence, 5'-CCA CAC GGA GAT CCC AGA
AGG AAT TA-3' and Tau- antisence, 5'-ATT TCC TGT
CCT GTC TTT GCT GGC-3' [7]; Tau6-sence 5'- TAC
ACC ATG CAC CAA GAC CA-3' and Tau6-antisence 5'-
GTC TCC AAT GCC TGC TTC TT-3 [25]; GSK3β-sence
5'-CTA AGG ATT CGT CAG GAA CAG-3' and GSK3β-
antisence 5'-TTG AGT GGT GAA GTT GAA GAG-3
[26]; CDK5-sence 5'-ACTGTGTTCAAGGCTAAAA
ACC-3' and CDK5-antisence 5'-CAATTTCAACTC-
CCCATTCC-3' [27]; β-actin-sence 5'-CTA CAA TGA
GCT GCG TGT GGC-3' and β-actin-antisence 5'-CAG
GTC CAG ACG CAG GAT GGC-3' [28]. Real time-PCR
was performed using a supermix containing the fluores-
cent dye SYBR green (Applied Biosystems) as described
previously [29], briefly, 1 μl of reverse transcription prod-
uct, 12.5 μl of 2× SYBR Green PCR Master Mix, 1 μl of
each primer (10 μM) and 9.5 μl H2O were mixed in a total
volume of 25 μl. PCR was performed on a 7500 Fast Real-
Time PCR System (Applied Biosystems), under following
condition 94°C for 15 s, 55°C for 30 s, and 72°C for 30 s,
total 40 cycles. The increases in fluorescence were col-
lected and the expressive level of each specific mRNA
was determined relative to that of the individual β-actin.
All real time-PCR reactions were performed in triplicate.
Quantitative and statistical analysis
Quantitative analysis of immunoblot images was carried
out using Image Total Tech software (Pharmacia). Briefly,
the image of immunoblot was scanned with Typhoon
(Pharmacia) and digitalized, saved in TIF format. The
values of each target blot were evaluated. All data are pre-
sented as the mean ± SD. Student's unpaired t test for
comparison of means was used to compare groups. Dif-
ferences were considered significant at a P value < 0.05.
Ethical approval
This study was approved by the Ethical Committee of
National Institute for Viral Disease Prevention and Con-
trol, China CDC.
Results
Increase of total tau in the brain tissues of the scrapie-
infected hamsters
To address the presences of PrPSc in the brain tissues of
scrapie-infected animals, 10% brain homogenates of five
strain 263K- and five 139A-infected hamsters were
digested by PK and analyzed with PrP specific Western
blots. Three PK-resistant PrP bands were identified in all
infected samples, which moved at the position from Mr.Wang et al. BMC Infectious Diseases 2010, 10:86
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21 to 27 kDa (Figure 1), representing di-, mono- and agly-
cosal forms.
T o assess the possible changes of tau in the brains of
scrapie experimental hamsters at the terminal stage, the
amounts of tau protein in brains were evaluated by West-
ern blots with a tau-specific mAb, which was confirmed
not to be influenced by the process of tau phosphoryla-
tion. At the experimental condition, tau-specific signals
at the position of 63 kDa were detected. Compared with
the healthy hamsters at similar ages, the signal intensities
in agent 263K- or 139A-infected hamsters were obviously
higher. Meanwhile, the levels of β-actin in the brain tis-
sues were comparable between the infected and healthy
groups (Figure 2A). To obtain more precise data, the gray
value of tau signal in each sample was equilibrated with
the individual value of β-actin. It showed that the mean
relative quantities of tau protein in the brains of 263K- or
139A-infected hamsters were significantly higher than
those of the healthy ones (Figure 2B, P < 0.05).
More active transcription of tau mRNA in the brain tissues 
of the infected hamsters
Tau is encoded via the transcription of a single gene by
alternative splicing, resulting in six isoforms [3]. To assess
the transcription of tau mRNA in brains, several specific
primer pairs targeting the tau isoforms Tau-2, Tau-4 and
Tau-6 were designed based on the mouse tau sequences.
RT-PCR assays using extracted RNA from normal and
scrapie-infected hamsters as the templates revealed a 187
bp product with Tau-2-specific primers and a 127 bp
fragment with Tau-4-specific primers, possibly repre-
senting the tau isoform of 372 amino acid residues and
isoform of 432 amino acid residues, while the primers for
Tau-6 failed to produce positive product (data not
shown). To evaluate the transcriptional levels of Tau-2
and Tau-4 in the brain of each animal, real time-PCR
reactions were performed. In addition, the transcription
of the housekeeping gene encoding β-actin was also eval-
uated as an internal control. After equilibrated with Ct
value of respective β-actin, the mean Ct values of Tau-2
and Tau-4 of each hamster were calculated from the data
of three independent reactions. Analysis of the relative
intensities of various groups showed that the levels of
Tau-2 transcript in the 263K- and 139A-infected ham-
sters were slightly increased, but no significant difference
was identified between the infected and the normal con-
trols (Figure 3). The level of Tau-4 mRNA was remarkably
increased in the brain tissues of 263K-infected (3.49-fold)
and 139A-infected hamsters (3.20-fold). It highlights that
the transcription of Tau-4 in the brains of scrapie-
infected hamsters is more active at the terminal stage.
Changes of phosphorylated tau profiles in the brain tissues 
of the scrapie-infected hamsters
To see the difference in the patterns of tau phosphoryla-
tion, all brain homogenates were screened by the Western
blots with various p-tau-specific antibodies, including
pAb TAU [pS396], pAb TAU [pS404] and mAb AT8,
which recognize the tau proteins phosphorylated at Ser-
ine 396, Serine 404 and Serine 202/Thr 205, respectively.
Antibody TAU [pS396] and TAU [pS404] revealed the
same reactive profiles that the signal intensities in the
hamsters infected with agent 263 K or 139 A were obvi-
ously lower than that of normal ones (Figure 4A). Scan-
ning the image of each blots identified the mean relative
quantities of p-tau (Ser396 and Ser404) in the infected
hamsters were remarkably lower than that in the control
group (P < 0.001, Figure 3).
A 63-kDa p-tau (Ser202/Thr205)-specific immunoblot
was detected in the brain homogenates by the Western
blot with mAb AT8. Contrast to the situation of p-tau
(Ser396 and Ser404), mAb AT8 revealed the different pat-
tern that the level of p-tau (Ser202/Thr205) in the brains
infected with agent 263 K or 139 A was clearly stronger
than that of the normal controls (Figure 4A). The mean
relative quantities of p-tau (Ser202/Thr205) in the
infected hamster brains were significantly higher than
that in the normal controls (P < 0.001, Figure 4B). These
data imply that the phosphorylating profiles of tau pro-
teins in the brains of scrapie-infected hamsters changed
at their clinically terminal stage.
Figure 1 Western blot analysis of PrPSc in the brain tissues of 
scrapie agents 263 K- and 139A-infected hamsters collected at 
the moribund stage. For detection of PrPSc, all tested brain homoge-
nates were digested with a final concentration of 50 μg/ml PK at 37°C 
for 60 min. Same amounts of individual brain homogenate were load-
ed in 15% SDS-PAGE. The scrapie agents were shown on the top of the 
graphs. PrPSc specific immunoblots (non-, mono- and di-glycosylated 
PrP isoforms) were indicated by arrows on the left and molecular mass 
markers were indicated to the right.
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Lower level of GSK3β and higher level of CDK5 in the brain 
tissues of the scrapie-infected hamsters
GSK3β activity is believed to coincide with tau hyper-
phosphorylation at the AT8 and PHF-1 sites [7]. To test
the possible changes of GSK3β in the central nerve tis-
sues of animals with TSE, the expressive and transcrip-
tional levels of GSK3β in the brains of normal and
scrapie-infected hamsters were evaluated by GSK3β-spe-
cific Western blot and real-time PCR. Western blots
identified that the GSK3β signals in 263K- or 139A-
infected hamsters were obviously weaker than that in
normal controls (Figure 5A). Analysis of the immunob-
lots of GSK3β showed that the relative quantities of
GSK3β signals in the groups of 263K- or 139A-infected
hamsters were clearly lower (Figure 5B, P < 0.05). Real-
time PCR for the transcription of GSK3β also revealed
the similar pattern, that the levels of GSK3β transcript
were downregulated by 0.03-fold in the brain of 263K-
infected hamsters and 0.06-fold in 139A-infected ham-
s t e r s .  T o  s e e  t h e  s t a t u s  o f  C D K 5  i n  b r a i n s  o f  s c r a p i e
experimental hamsters, same brain homogenates from
263K- or 139A-infected hamsters and healthy ones were
employed into CDK5-specific Western blots and real-
time PCR. Western blots showed much stronger CDK5
signals in all tested brains of scrapie experimental ham-
sters, whose mean relative intensities were clearly higher
than that of healthy ones (P < 0.001, Figure 5B). Real-time
PCR for CKD5 demonstrated that the amounts of CDK5
transcript were remarkably upregulated in the brain tis-
sues of 263K-infected (2.3-fold) and 139A-infected ham-
sters (1.87-fold) (Figure 5C).
Figure 2 Comparative analysis of the level of tau protein in the brain tissues of normal, scrapie agent 263K- and 139A-infected hamsters 
collected at the moribund stage. A. Western blots. Same amounts of individual brain homogenate were loaded in 12% SDS-PAGE. The scrapie 
agents as well as normal control were shown on the top of the graphs. Tau specific immunoblots were indicated by arrows on the left and molecular 
mass markers were indicated to the right. B. Quantitative analyses of each gray numerical value of tau vs that of β-actin. The average values were cal-
culated from five individual infected hamsters or four individual normal hamsters and presented as mean ± SD. Statistical differences compared with 
normal controls were illustrated as P < 0.05 and P < 0.01.
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Changes of tau profiles and phosphate kinases are time-
relative events
In order to investigate the dynamic changes of tau, p-tau
(Ser396), p-tau (Ser404), p-tau (Ser202/Thr205), GSK3β
and CDK5 in the brains of scrapie-infected hamsters dur-
ing incubation period, the expressive and transcriptional
levels of these biomarkers were evaluated by Western
blots and real-time PCR, respectively. Brain samples of
the agent 263K-infected hamsters at the 20th, 40th, 50th,
60th and 70th days after inoculation were collected.
Western blots showed that the signals of tau, p-tau
(Ser202/Thr205), and CDK5 became stronger and that of
p-tau (Ser396), p-tau (Ser404) and GSK3β became
weaker in the infected specimens compared with the nor-
mal controls (F igure 6A). Analysis of the gray value of
each sample equilibrated with the individual value of β-
actin showed obviously increase of tau, p-tau (Ser202/
Thr205) and CDK5 signals, and decrease of p-tau
(Ser396), p-tau (Ser404) and GSK3β signals in the
infected brain samples (Figure 6B). Real-time PCR tests
revealed that alone with the incubation the mRNA levels
of Tau4 and CDK5 increased remarkably, whereas that of
GSK3β became degressive (Figure 6C). In line with the
above observations, the transcripts of Tau2 remained rel-
atively stable. These results indicate that changes of tau
profiles and phosphate kinases happen much earlier than
the onset of the clinical manifestations, showing a time-
relative pattern.
Discussion
AD, the most common form of dementia, is pathologi-
cally characterized by Aβ-amyloid plaques and neurofi-
brillary tangles [5]. The amyloid cascade hypothesis
implies that the extracellular deposition of Aβ is the ini-
tial and seminal event of AD pathogenesis and the intran-
euronal formation of neurofibrillary changes, composed
of hyperphosphorylated tau protein, is a consequence of
it. In prion disease, a consistent subset of GSS patients,
such as some with the most common P102L PRNP muta-
tion, has been shown to harbor neurofibrillary changes
further suggesting that tau pathology is downstream from
the extracellular deposition of amyloid, either made up of
Aβ or PrP [30]. But this has been partially questioned by
the fact that in most cases of human prion diseases, the
deposition of abnormal PrP in the brain does not induce a
tauopathy.
In this study, Western blot and real-time PCR provide
the evidences of higher level of tau protein in the brain
homogenates of scrapie-infected hamsters. Increased tau
protein probably reflects neuronal, preferentially axonal
damage or degeneration. Although the scrapie hamster-
adapted agent 263 K and agent 139 A bear distinctly dif-
ferent incubation times [31], the similar increased brain
tau at the terminal stages indicates a common phenome-
non of scrapie experimental animals, neither related with
scrapie strains nor incubation periods.
Figure 3 Comparative analysis of the mRNA transcription of Tau2 and Tau4 in the brain tissues of normal and scrapie-infected hamsters 
collected at the moribund stage by real time PCR. The transcription level of each specific mRNA was determined relative to that of the individual 
β-actin. The relative intensity of each gene from scrapie-infected hamsters was relative to that of respective gene from normal hamsters that was set 
to 1. Data are representative of three independent experiments.
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The phosphorylating status of tau is crucial for its bio-
logical activities. Aberrant tau phosphorylation can dis-
rupt ax onal transport, which has been proposed as an
underlying mechanism possibly giving rise to neurode-
generation [32]. Tau mutants, with serine/threonine tar-
gets of GSK3 mutated to glutamate to mimic a
permanent state of phosphorylation, are transported at a
significantly increased rate compared to wild-type tau.
Conversely, tau mutants, in which alanine replaced ser-
ine/threonine to mimic permanent dephosphorylation,
are transported at a decreased rate compared to wild-
type tau [32]. The diverse phosphorylating statuses of tau
have been also described in human prion diseases, e.g.
increased p-tau in GSS but not in sporadic CJD. Com-
pared with healthy hamsters, inoculations of two scrapie
strains into experimental hamsters cause decreased of p-
tau at Ser396/Ser404 and increased of p-tau at Ser202/
Thr205 in the brains. Tau protein has a series of potential
phosphorylating sites, among them only p-tau at Ser396,
Ser404 and Ser202/Thr205 has been addressed in this
study. One might speculate there are other profiles of p-
tau in the brains of human and animal TSEs. However,
highly depressed p-tau at Ser396/Ser404 and markedly
raised p-tau at Ser202/Thr205 in brains of the hamsters
infected by scrapie strongly indicate these changes of p-
tau profiles are TSE related events.
CDK5 and GSK3β have been identified as major candi-
dates mediating tau phosphorylation at sites characteris-
tic for neurodegenerative tauopathies. Specific inhibition
of GSK3β reduces tau phosphorylation and significantly
decreases the overall rate of axonal transport of tau in rat
cortical neurons [32]. Alterations of the patterns of other
phosphorylation kinase, e.g. CK2 and its subunits, have
been also observed in the brain tissues of the experimen-
Figure 4 Analysis of the levels of p-tau (Ser396), p-tau (Ser404) and p-tau (Ser202/Thr205) in the brain tissues of normal and scrapie-infect-
ed hamsters collected at the moribund stage. A. Western blots. Same amounts of individual brain homogenate were loaded in 12% SDS-PAGE. The 
scrapie agents and normal controls were shown on the top of the graphs. Various specific immunoblots were indicated by arrows on the left. B. Quan-
titative analysis of each gray numerical value of p-tau (Ser396), p-tau (Ser404) and p-tau (Ser202/Thr205) vs that of β-actin. The average values were 
calculated from five individual infected hamsters or four individual normal hamsters and presented as mean ± SD. Statistical differences compared 
with controls were illustrated as P < 0.05 and P < 0.01.
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tal and naturally-occurred animal and human TSEs [31].
In this study, we have firstly described that the cerebral
level of GSK3β declines and that of CDK5 increases dur-
ing scrapie pathogenicity. It is reasonable to speculate
that the changes of p-tau profiles in the brains of TSEs
may link with the alternations of protein kinases.
Our data reveal that the changes of tau profiles and
phosphate kinases in scrapie-infected hamsters are time-
relative events. In line with the previous observations of
PrPSc  deposition and neuropathological abnormality,
changes of tau and kinases in brains of scrapie experi-
mental animals appear much earlier than the onset of
clinical manifestations. Moreover, gradually declined
GSK3β and raised CDK5 levels correspond well with the
decrease of p-tau (Ser396 and Ser404) and increase of p-
tau (Ser202/Thr205), respectively. These phenomena
may highlight the possibility that the increase of p-tau
(Ser202/Thr205) is due to the higher level of CDK5 and
depression of p-tau (Ser396 and Ser404) owes to the
lower level of GSK3β. Additionally, GSK3β and CDK5
seems to show individual tropism on phosphorylating
tau, which GSK-3β prefers to act on tau at the C-terminus
and CDK5 tends to target the N-terminus [12]. The cata-
lytic characteristics of these two kinases on tau may help
to explain the special p-tau profiles in scrapie-infected
hamsters. Further immunohistochemistry assays for eval-
uating the alterations of these biofactors in brains assays
for illustrating potential pathological characteristics of
tau in scrapie will help to clarify the pathogenesis of prion
disease.
Figure 5 Analysis of GSK3β and CDK5 in the brain tissues of normal and scrapie-infected hamsters collected at the moribund stage. A. West-
ern blots. Same amounts of individual brain homogenate were loaded in 12% SDS-PAGE. The scrapie agents and normal controls were shown on the 
top of the graphs. Various specific immunoblots were indicated by arrows on the left. B. Quantitative analysis of each gray numerical value of GSK3β 
and CDK5 vs that of β-actin. The average values were calculated from five individual infected hamsters or four individual normal hamsters and pre-
sented as mean ± SD. Statistical differences compared with controls were illustrated as P < 0.05 and P < 0.01. C. Real time PCR analysis of the mRNA 
transcription of GSK3β and CDK5. The transcription level of each specific mRNA was determined relative to that of the individual β-actin. The relative 
intensity of each gene from scrapie-infected hamsters was relative to that of respective gene from normal hamsters that was set to 1. Data are repre-
sentative of three independent experiments.
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Conclusion
Our results suggest that changes of profiles of p-tau at
Ser396, Ser404 and Ser202/Thr205 are illness-correlative
phenomena in TSEs, which may arise of the alteration of
phosphate kinases. Alterations of tau and kinases in the
brains of TSE animals during pathogenicity may consist
of a complicate network. It is still unclear when and how
these components function and impact each other.
Except for the deposits of PrPSc as the initiative agent,
alterations of these bioactive proteins are either interme-
diate or consequent events in TSE pathogenicity and pro-
posed the potential linkage of these bioactive proteins
with the pathogenesis of prion diseases.
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